IM Cannabis Corp.
IMCC- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001792030
No open-market purchases or sales by IM Cannabis Corp. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $62.0K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding IM Cannabis Corp. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 34 | 32 | −2 |
| Shares | 9.15M | 9.32M | +169.4K (+1.9%) |
| Value | $19.4M | $5.99M | −$13.5M (−69.2%) |
New holders (3)
Institutions that held IM Cannabis Corp. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| StoneX Group Inc. | 15,000 | $9.57K | 0.00% |
| Morgan Stanley | 44 | $0 | 0.00% |
| CoreCap Advisors, LLC | 22 | $0 | 0.00% |
Sold out (5)
Institutions that held IM Cannabis Corp. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Cutler Group LP | 2,360 | $5.00K |
| Koshinski Asset Management, Inc. | 1,000 | $2.14K |
| Citigroup Inc | 632 | $1.00K |
| 1832 Asset Management L.P. | 609 | $1.00K |
| Tower Research Capital LLC (TRC) | 1 | $0 |